BIOAFFINITY TECHNOLOGIES INC (BIAF)

bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth

bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening

BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q4 2023

bioAffinity Technologies just reported results for the fourth quarter of 2023.

BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips bioAffinity Technologies (NASDAQ:BIAF) just reported results for the fourth qua...

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

/PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity...

bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

/PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that BioAffinity...

bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung

bioAffinity Technologies News Update

Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice

bioAffinity Technologies In The News

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

bioAffinity Technologies In the News

bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

bioAffinity Technologies files for a $25M mixed shelf offering (NASDAQ:BIAF)

BioAffinity Technologies (BIAF) has filed a prospectus for a mixed shelf offering to raise up to $25M, presenting potential investment opportunities.

bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales

bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference

bioAffinity Technologies files to sell 3.09M units (NASDAQ:BIAF)

bioAffinity Technologies (BIAF) disclosed in an SEC filing on Wednesday after the bell a prospectus to offer and sell 3.09 million units.Each unit will consist of one share of common...

bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services

bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference

bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update

AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer